Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.2700
0.00 (0.00%)
At close: Jul 15, 2025, 4:00 PM AEST
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 5.12 million as of July 18, 2025.
Market Cap
5.12M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
Market Cap Chart
Since April 5, 2024, Cambium Bio's market cap has decreased from 7.97M to 5.12M, a decrease of -35.75%. That is a compound annual growth rate of -29.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 5.12M | -3.63% |
| Dec 31, 2024 | 5.31M | -33.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 124.63B |
| Pro Medicus | 34.26B |
| Cochlear | 20.29B |
| Sonic Healthcare | 13.65B |
| Ramsay Health Care | 8.93B |
| Telix Pharmaceuticals | 8.55B |
| Ansell | 4.49B |
| Mesoblast | 3.08B |